Article
The CD28-Transmembrane Domain Mediates Chimeric Antigen Receptor Heterodimerization With CD28
23 Mar 2021
Abstract excerpt
Anti-CD19 chimeric antigen receptor (CD19-CAR)-engineered T cells are approved therapeutics for malignancies. The impact of the hinge domain (HD) and the transmembrane domain (TMD) between the extracellular antigen-targeting CARs and the intracellular signaling modalities of CARs has not been systemically studied. In this study, a series of 19-CARs differing only by their HD (CD8, CD28, or IgG 4 ) and TMD (CD8 or...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
